Merck Tumbles on Texas Verdict

Autodesk posts strong profits, Gap lowers outlook for the year, and more of Friday's stocks in the news

Merck (MRK ) shares fell after a Texas jury awards total damages of $253 million in the case of the death of a man who took its painkiller Vioxx. Merck says it will appeal the verdict on its belief the plaintiff did not meet the standard set by Texas law to prove Vioxx caused the man's death.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.